NBDC Research ID: hum0556.v1

 

SUMMARY

Aims: By analyzing thoracic tumor specimens and normal tissues, this study aims to elucidate the pathophysiology of cancer, thereby contributing to cancer prevention, the establishment of diagnostic and therapeutic methods, and the development of novel treatments.

Methods: ChIP-seq

Participants/Materials: Tumor samples from 17 patients with lung cancer

 

Dataset IDType of DataCriteriaRelease Date
JGAS000903 NGS (ChIP-seq) Controlled-access (Type I) 2026/06/23

*Release Note

* Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

JGAS000903

Participants/Materials

lung cancer (ICD10: C349): 17 cases

     tumor tissue: 24 samples (FFPE samples)

Targets ChIP-seq
Target Loci for Capture Methods -
Platform Illumina [HiSeq 2500]
Library Source DNA extracted from tumor tissues was used for the library construction. Anti-histone antibody (H3K27ac) was used for immunoprecipitation.
Cell Lines -
Library Construction (kit name) ThruPLEX DNA-Seq Kit
Fragmentation Methods Ultrasonic fragmentation (Bioruptor)
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 50 bp
QC

- Read trimming using Trimmomatic (removal of TruSeq3 adapters; trimming when the average quality score across a 4-base sliding window falls below 20; removal of reads shorter than 36 bp)

- Post-mapping filtering using Samtools (removal of reads with MAPQ < 20)

Mapping Methods Bowtie2
Reference Genome Sequence hg19/GRCh37
Detecting Methods for peaks MACS2
Japanese Genotype-phenotype Archive Dataset ID JGAD001047
Total Data Volume 38 GB (fastq, bed)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Takashi Sato

Affiliation: Department of Respiratory Medicine, Kitasato University School of Medicine

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
KAKENHI Grant-in-Aid for Early-Career Scientists Exploration of differentiation programs in lung cancers using epigenomic profiling 20K17192
KAKENHI Grant-in-Aid for Scientific Research (C) Exploring the roles of master regulators in differentiation programs of various lung cancers 23K07609
KAKENHI Grant-in-Aid for Scientific Research (C) Search for MYC-related biomarkers for lung neuroendocrine neoplasms 22K08288
MSD Life Science Foundation, Public Interest Incorporated Foundation Heterogeneity and plasticity of differentiation programs in lung cancer -
Medical Research Grant, Takeda Science Foundation Deciphering the Heterogeneity and Plasticity of Differentiation Programs that Define Lung Cancer Phenotypes -
The Naito Foundation Investigating Plasticity in Lung Cancer Progression and Adaptation -

 

PUBLICATIONS

 

USRES (Controlled-access Data)

TitleDOIDataset ID
1 Epigenomic profiling of neuroendocrine lung cancers identifies a classical-neuroendocrine ASCL1/NKX2-1 subtype and a SOX11-associated differentiation axis linked to reduced immunogenicity doi: 10.1016/j.lungcan.2026.109464 JGAD001047
2
Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use